Incorrect Barcode Could Delay Treatment for Hospira Product

Incorrect Barcode Could Delay Treatment for Hospira Product

January 8, 2016

Hospira, Inc. has announced a recall for a product that features an incorrect barcode.

The pharmaceutical manufacturer is recalling one lot of injectable magnesium sulfate. The product is intended to prevent and control seizures in patients suffering from preeclampsia and eclampsia. No reports of adverse events have been recorded.

The product in question features two barcodes on the overwrap and on the primary container. While the barcode on the former is correct, there is potential for the primary container barcode to be mislabeled with the barcode for a sodium chloride injection. The printed names appearing with each barcode are correct.

The incorrect barcode could result in the delay in treatment of magnesium sulfate that can result in life-threatening seizures, stroke, cerebral hemorrhage and maternal death.

The product is packaged 50 mL fill, in 100 mL container bags and sold 24 bags per carton (NDC: 0409-6729-24, Lot 53-113-JT, Expiry 11/01/2016). The lot was distributed nationwide in the U.S. to wholesalers, distributors and hospitals from September 2015 to November 2015.

Anyone with an existing inventory of the recalled lot should stop use and distribution and quarantine the product immediately.

Consumers with questions about the recall can contact Hospira Global Complaint Management by phone at (800) 441-4100 or by email at